New York Mortgage Trust (NASDAQ:NYMT – Get Rating) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Wednesday.
A number of other research firms also recently commented on NYMT. Keefe, Bruyette & Woods decreased their price target on New York Mortgage Trust to $2.50 and set a “market perform” rating for the company in a research note on Wednesday, March 8th. Jonestrading restated a “hold” rating on shares of New York Mortgage Trust in a research note on Wednesday, March 1st. Finally, LADENBURG THALM/SH SH downgraded New York Mortgage Trust from a “buy” rating to a “neutral” rating and set a $12.00 target price for the company. in a research note on Friday, February 24th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $12.08.
New York Mortgage Trust Stock Up 3.8 %
NASDAQ:NYMT opened at $9.29 on Wednesday. The company has a market capitalization of $849.20 million, a price-to-earnings ratio of -2.58 and a beta of 1.78. New York Mortgage Trust has a one year low of $8.28 and a one year high of $15.00. The stock has a 50-day simple moving average of $11.31 and a 200 day simple moving average of $10.89. The company has a debt-to-equity ratio of 2.36, a quick ratio of 9.77 and a current ratio of 9.77.
Institutional Investors Weigh In On New York Mortgage Trust
About New York Mortgage Trust
New York Mortgage Trust, Inc is a real estate investment trust, which engages in the acquisition, investment, finance, and management of mortgage-related single-family and multi-family residential assets. Its investment portfolio includes credit sensitive single-family and multi-family assets. The company was founded on September 26, 2003 and is headquartered in New York, NY.
Further Reading
- Get a free copy of the StockNews.com research report on New York Mortgage Trust (NYMT)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts DefendĀ
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for New York Mortgage Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for New York Mortgage Trust and related companies with MarketBeat.com's FREE daily email newsletter.